Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,394 | 1,423 | 99.6% |
| Education | $81.80 | 10 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,575 | 187 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,377 | 162 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,200 | 115 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,093 | 130 | $0 (2024) |
| Lilly USA, LLC | $1,516 | 96 | $0 (2024) |
| ABBVIE INC. | $1,389 | 100 | $0 (2024) |
| Amgen Inc. | $1,307 | 67 | $0 (2024) |
| PFIZER INC. | $1,065 | 125 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $990.10 | 72 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $583.50 | 34 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,546 | 187 | AstraZeneca Pharmaceuticals LP ($517.27) |
| 2023 | $3,131 | 182 | ABBVIE INC. ($457.15) |
| 2022 | $3,056 | 191 | Boehringer Ingelheim Pharmaceuticals, Inc. ($375.43) |
| 2021 | $3,082 | 212 | GlaxoSmithKline, LLC. ($440.00) |
| 2020 | $1,610 | 92 | Novo Nordisk Inc ($371.36) |
| 2019 | $2,430 | 174 | AstraZeneca Pharmaceuticals LP ($398.94) |
| 2018 | $2,279 | 206 | PFIZER INC. ($376.60) |
| 2017 | $2,342 | 189 | Novo Nordisk Inc ($266.88) |
All Payment Transactions
1,433 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Obesity | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: PAIN | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Cardio-renal | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.39 | General |
| Category: Cardiovascular | ||||||
| 11/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: PAIN | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Gastroenterology | ||||||
| 11/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Obesity | ||||||
| 10/29/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,112 | 1,837 | $215,877 | $128,440 |
| 2022 | 15 | 721 | 1,063 | $144,313 | $69,841 |
| 2021 | 24 | 1,076 | 1,587 | $221,128 | $111,103 |
| 2020 | 23 | 941 | 1,422 | $196,573 | $91,746 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 160 | 387 | $62,515 | $31,465 | 50.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 92 | 92 | $28,200 | $25,349 | 89.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 103 | 103 | $15,450 | $12,315 | 79.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 56 | 257 | $19,275 | $11,395 | 59.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 141 | 205 | $22,550 | $11,353 | 50.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 99 | 99 | $8,910 | $7,342 | 82.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 53 | 189 | $10,395 | $6,530 | 62.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 31 | 31 | $17,050 | $5,079 | 29.8% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 30 | 30 | $6,000 | $4,147 | 69.1% |
| 99484 | Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | Office | 2023 | 20 | 107 | $5,885 | $3,349 | 56.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 101 | 102 | $4,590 | $2,945 | 64.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 84 | 84 | $3,780 | $2,474 | 65.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $3,750 | $1,649 | 44.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 30 | 30 | $1,500 | $1,139 | 75.9% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 13 | 16 | $1,955 | $470.99 | 24.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 11 | 11 | $825.00 | $446.05 | 54.1% |
| 92250 | Photography of the retina | Office | 2023 | 16 | 17 | $1,615 | $423.00 | 26.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 28 | 30 | $297.00 | $250.46 | 84.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 21 | $840.00 | $197.10 | 23.5% |
| 90471 | Administration of vaccine | Office | 2023 | 11 | 11 | $495.00 | $121.36 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 310 | $50,110 | $24,335 | 48.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 91 | 91 | $13,650 | $11,137 | 81.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 124 | 167 | $18,435 | $8,264 | 44.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 59 | 60 | $5,370 | $4,133 | 77.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 35 | 87 | $6,365 | $3,999 | 62.8% |
About Dr. Daniel Kambic, DO
Dr. Daniel Kambic, DO is a Family Medicine healthcare provider based in Steelton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487616991.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Kambic, DO has received a total of $21,476 in payments from pharmaceutical and medical device companies, with $3,546 received in 2024. These payments were reported across 1,433 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($21,394).
As a Medicare-enrolled provider, Kambic has provided services to 3,850 Medicare beneficiaries, totaling 5,909 services with total Medicare billing of $401,130. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Steelton, PA
- Active Since 04/03/2006
- Last Updated 04/25/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487616991
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,309
- JARDIANCE (Drug) $1,242
- XIFAXAN (Drug) $1,030
- FARXIGA (Drug) $823.99
- Ozempic (Drug) $815.95
- VRAYLAR (Drug) $800.84
- BREZTRI (Drug) $643.85
- Kerendia (Drug) $583.50
- MOUNJARO (Drug) $569.07
- Saxenda (Drug) $546.73
- XARELTO (Drug) $476.09
- Vascepa (Drug) $458.87
- STIOLTO RESPIMAT (Drug) $448.42
- EVENITY (Biological) $418.79
- TRULICITY (Drug) $417.80
- Wegovy (Drug) $393.25
- NURTEC ODT (Drug) $388.98
- SYMBICORT (Drug) $373.48
- QULIPTA (Drug) $364.19
- Aimovig (Biological) $359.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Steelton
Kaitlin Plummer, Do, DO
Family Medicine — Payments: $14,016
Arif Shaikh, Md, MD
Family Medicine — Payments: $3,394
William Wewer, D.o, D.O
Family Medicine — Payments: $3,236
Deanne Endy, Do, DO
Family Medicine — Payments: $1,383
Maryjo Szada, Md, MD
Family Medicine